Molecular dynamics simulations of the interactions of charge-neutral PAMAM dendrimers with pulmonary surfactant

Soft Matter ◽  
2011 ◽  
Vol 7 (8) ◽  
pp. 3882 ◽  
Author(s):  
Xubo Lin ◽  
Yang Li ◽  
Ning Gu
2017 ◽  
Vol 19 (27) ◽  
pp. 17568-17576 ◽  
Author(s):  
Yan Xu ◽  
Li Deng ◽  
Hao Ren ◽  
Xianren Zhang ◽  
Fang Huang ◽  
...  

Three types of nanoparticles, including hydrophobic nanoparticles, hydrophilic nanoparticles, and hydrophilic nanoparticles coated with lipids, were found by our molecular dynamics simulations to be transported across the pulmonary surfactant monolayer, but via different pathways, which affect their subsequent interactions with target cell membranes.


2018 ◽  
Vol 5 (8) ◽  
pp. 1921-1932 ◽  
Author(s):  
Zhen Luo ◽  
Shixin Li ◽  
Yan Xu ◽  
Zengshuai Yan ◽  
Fang Huang ◽  
...  

We report using molecular dynamics simulations that the shape plays a dominant role in inhaled nanoparticle translocation through the pulmonary surfactant layer.


Nanomedicine ◽  
2020 ◽  
Author(s):  
Natalia Ortiz ◽  
Pilar A Vásquez ◽  
Felipe Vidal ◽  
Carola F Díaz ◽  
José L Guzmán ◽  
...  

The purpose of this study was to design a polyamidoamine (PAMAM)-based nanovector for the efficient delivery of methotrexate to U87 glioma cells. To this end, 0–100% acetylated PAMAM dendrimers of the fourth generation were synthesized and evaluated using drug encapsulation measurements, molecular dynamics simulations, neurotoxicity assays and neuronal internalization experiments. The best system was tested as a nanovector for methotrexate delivery to U87 glioma cells. The authors found that 25% acetylated PAMAM dendrimers of the fourth-generation combine low intrinsic toxicity, large drug complexation capacity and efficient internalization into hippocampal neurons. Nanovector complexation enhances the cytotoxic response of methotrexate against U87 glioma cells compared with free drug solutions. In conclusion, 25% acetylated PAMAM dendrimers of the fourth-generation increase drug uptake by glioma cells and thereby act as efficient nanovectors for methotrexate delivery.


Langmuir ◽  
2018 ◽  
Vol 34 (30) ◽  
pp. 9054-9063 ◽  
Author(s):  
Yan Xu ◽  
Shixin Li ◽  
Zhen Luo ◽  
Hao Ren ◽  
Xianren Zhang ◽  
...  

Nanoscale ◽  
2014 ◽  
Vol 6 (5) ◽  
pp. 2759-2767 ◽  
Author(s):  
Xubo Lin ◽  
Tingting Bai ◽  
Yi Y. Zuo ◽  
Ning Gu

Understanding the interactions between nanoparticles and pulmonary surfactant can help promote the nanoparticle-based respiratory drug carrier systems.


ACS Omega ◽  
2018 ◽  
Vol 3 (2) ◽  
pp. 2001-2009 ◽  
Author(s):  
Pedro B. P. S. Reis ◽  
Diogo Vila-Viçosa ◽  
Sara R. R. Campos ◽  
António M. Baptista ◽  
Miguel Machuqueiro

2016 ◽  
Vol 2 (1) ◽  
pp. 1229830 ◽  
Author(s):  
David E. Jones ◽  
Albert M. Lund ◽  
Hamidreza Ghandehari ◽  
Julio C. Facelli ◽  
Jacob Kongsted

Sign in / Sign up

Export Citation Format

Share Document